Stock listing

OTC:NPHC Nutra Pharma Corp. Stock

Follow Nutra Pharma Corp. into a list and get an email when it puts out news.

Share price · OTC:NPHC

$0.0002 USD 0.0000 (0.0%)

Close on Nov 18, 2026

Past year 0.0% · daily closes, Nov 20, 2025 – Nov 18, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 18, 2026
Volume
28,737 sharesNov 18, 2026
Market cap
$1.43M USDAt the close on Nov 18, 2026 · price × 7.16B shares outstanding
52-week range
$0.0001 – $0.0050 USDLowest and highest trades, Nov 20, 2025 – Nov 18, 2026
Traded on an average day
$43 USDMedian day 150,000 shares · last 3 months, Aug 24, 2026 – Nov 18, 2026
Nutra Pharma Corp. logo

Daily closes

Last 3 months, Aug 24, 2026 – Nov 18, 2026 · OTC:NPHC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.000228,737
$0.00020.00000.0%$0.0002$0.0002$0.000225,000
$0.00020.00000.0%$0.0002$0.0002$0.000212,402
$0.00020.00000.0%$0.0002$0.0002$0.00023,000,000
$0.00020.00000.0%$0.0002$0.0002$0.000296,035
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00025,000
$0.00010.00000.0%$0.0001$0.0001$0.0001125
$0.00010.00000.0%$0.0001$0.0001$0.00012,074,000
$0.00010.00000.0%$0.0001$0.0001$0.0001195,800
$0.00010.00000.0%$0.0001$0.0001$0.0001775
$0.00010.00000.0%$0.0001$0.0001$0.000160,710
$0.00010.00000.0%$0.0001$0.0001$0.0001721,263
$0.00010.00000.0%$0.0001$0.0001$0.0001125
$0.00010.00000.0%$0.0001$0.0001$0.0001234,500
$0.00010.00000.0%$0.0001$0.0001$0.0001150,000
$0.00010.00000.0%$0.0001$0.0001$0.000125,000
$0.00010.00000.0%$0.0001$0.0001$0.0001928,010
$0.00010.00000.0%$0.0001$0.0001$0.0001533
$0.00010.00000.0%$0.0001$0.0001$0.0001275
$0.00010.00000.0%$0.0001$0.0001$0.00011,102,689
$0.00010.00000.0%$0.0001$0.0001$0.0001162,053
$0.00010.00000.0%$0.0001$0.0001$0.0001600,000
$0.00010.00000.0%$0.0001$0.0001$0.000112,050
$0.00010.00000.0%$0.0001$0.0001$0.0001200,078
$0.00010.00000.0%$0.0001$0.0001$0.0001301,124
$0.00010.00000.0%$0.0001$0.0001$0.0001100,000
$0.00010.00000.0%$0.0001$0.0001$0.0001543,139
$0.00010.00000.0%$0.0001$0.0001$0.0001183,473
$0.00010.00000.0%$0.0001$0.0001$0.0001281,081
$0.00010.00000.0%$0.0001$0.0001$0.0001321,375
$0.00010.00000.0%$0.0001$0.0001$0.000155,000
$0.00010.00000.0%$0.0001$0.0001$0.0001150,000
$0.00010.00000.0%$0.0001$0.0001$0.00011,360,000
$0.00010.00000.0%$0.0001$0.0001$0.0001286,144
$0.00010.00000.0%$0.0001$0.0001$0.000110,000
$0.00010.00000.0%$0.0001$0.0001$0.0001838
$0.00010.00000.0%$0.0001$0.0001$0.0001400
$0.00010.00000.0%$0.0001$0.0001$0.00019,000
$0.00010.00000.0%$0.0001$0.0001$0.0001454,545

Splits

1 split · OTC:NPHC · every price before a split is adjusted for it

DayRatioWhat
1-for-40Consolidation
Ticker
OTC:NPHC
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

All Nutra Pharma Corp. news

Nutra Pharma Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
20 in all · newest Sep 28, 2018 · oldest 2015
Decks
1 deck · latest September 2010

Valuation

EV/sales 87.0× against a median of −2.0×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 18, 2026

Enterprise value
$13.99M USD
P/E
Loss
EV/sales
87.0×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
78.1%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
Under 6 months of closes

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Nutra Pharma Corp. · OTC:NPHCUS$1.43MUS$13.99Mn/a87.0×n/an/an/an/an/a
SOHM, Inc. · OTC:SHMNUS$1.74MUS$4.99Mn/a5.5×n/a0.5×−28.1%0.9×-0.10
PRF Technologies Ltd. · NASDAQ:PRFXUS$1.66M−US$9.82Mn/a−249×n/a0.1×n/a0.0×1.93
Jupiter Neurosciences, Inc. · NASDAQ:JUNSUS$1.63MUS$1.33Mn/a16.9×n/an/an/an/a1.88
Kairos Pharma, Ltd. · AMEX:KAPAUS$1.48M−US$1.65Mn/an/an/a0.4×n/a0.0×1.36
BioRestorative Therapies, Inc. · NASDAQ:BRTXUS$1.45M−US$2.11Mn/a−5.9×n/a0.5×n/a0.0×1.81
Aptevo Therapeutics Inc. · NASDAQ:APVOUS$1.40M−US$2.88Mn/an/an/a0.4×n/a1.0×0.93
Agentix Corp. · OTC:AGTXUS$1.35MUS$1.34Mn/an/an/an/an/an/a-0.73
Clearmind Medicine Inc. · NASDAQ:CMNDUS$1.33M−US$9.01Mn/an/an/a0.2×n/a0.0×0.29
Artelo Biosciences, Inc. · NASDAQ:ARTLUS$1.30MUS$1.34Mn/an/an/a0.2×n/a0.0×1.36
International Stem Cell Corporation · OTC:ISCOUS$1.28M−US$18.76M0.1×−2.0×n/a0.1×222.6%0.0×-0.52
Median of the othersUS$1.42M−US$1.88M0.1×−2.0×0.3×97.3%0.0×1.15

Team and board

Officers

OfficerRole
Michael FlaxChairman, Chief Executive Officer, Chief Financial Officer
Dale Vander PuttenChief Scientific Officer
Rik J DeitschOperations Manager
Stewart LonkyDirector - Audit & Compensation Committees

Board

DirectorRole
Michael FlaxChairman, Chief Executive Officer, Chief Financial Officer
Garry R PottruckDirector

Events

QuarterResultsShare move
Q3 2025Oct 16, 2025
Q4 2024Feb 26, 2025
Q3 2024Nov 27, 2024
Q2 2024Aug 28, 2024
Q1 2024May 29, 2024
Q4 2023Feb 28, 20240.0%
Q3 2023Nov 29, 2023
Q2 2023Aug 30, 2023
Q1 2023May 31, 20230.0%
Q4 2022Mar 1, 2023+100.0%
All 18 quarters
QuarterResultsShare move
Q3 2022Nov 21, 2022−40.0%
Q2 2022Aug 31, 20220.0%
Q1 2022Jun 1, 20220.0%
Q4 2021Mar 2, 20220.0%
Q3 2021Dec 1, 2021−15.0%
Quarter to Jun 30, 2021Sep 1, 2021+7.7%
Quarter to Mar 31, 2021Jun 2, 2021+8.1%
Quarter to Dec 31, 2020Mar 3, 2021−13.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2010)Investor deck26 slidesSeptember 2010

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue257.6K246.3K205.6K145.8K97.7K51.9K104.4K130.6K121.0K168.4K
Cost of revenue183.7K240.6K177.5K162.8K41.3K68.8K26.9K39.0K
Gross profit196.6K247.3K396.5K249.0K8.47K14.9K34.7K14.1K94.1K-54.6K
Selling, general and administrative1.13M1.18M2.08M1.93M1.10M1.20M1.39M1.48M1.99M
Operating income-1.46M-878.4K-887.0K-1.91M-1.99M-924.9K-1.23M-1.88M-1.38M-2.04M
Depreciation and amortization10.6K7.44K18.2K22.7K9.08K3.83K3.74K5.96K6.29K8.73K
EBITDA-1.45M-871.0K-868.8K-1.88M-1.98M-921.1K-1.23M-1.87M-1.38M-2.03M
Interest expense22.9K21.2K18.8K17.1K18.2K316.2K244.3K574.3K343.2K293.8K
Income before tax-2.05M-1.29M-1.39M8.18M-13.1M-769.2K-6.59M-3.88M-4.03M-3.45M
Net income-2.05M-1.29M-1.39M8.18M-13.1M-769.2K-6.59M-3.88M-4.03M-3.45M
Earnings per share, basic0.000.000.000.00-0.000.000.000.000.00-0.02
Earnings per share, diluted0.000.000.000.00-0.000.000.000.000.00-0.02

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents12.2K36.4K0090.9K31.2K
Short-term investments17.6K17.6K35.2K
Receivables22.4K21.7K46.0K37.1K32.5K17.1K15.1K30.6K
Inventory19.5K17.7K19.5K23.9K31.3K5.27K8.18K35.3K20.1K25.6K
Current assets459.6K374.8K314.1K333.6K533.8K55.4K57.8K115.4K357.6K185.1K
Property, plant and equipment25.8K10.4K17.8K80.0K44.7K14.7K6.76K10.5K16.5K13.6K
Total assets622.6K599.5K640.4K754.9K780.0K301.8K339.8K141.4K389.6K214.3K
Accounts payable853.6K802.3K763.0K727.4K672.4K599.4K583.2K475.4K393.0K958.0K
Current liabilities17.3M15.3M14.2M12.7M21.1M11.5M11.0M6.03M5.80M4.65M
Long-term debt136.6K140.2K143.7K51.4K
Total debt9.76M8.63M8.47M8.19M214.8K1.62M682.1K888.8K
Total liabilities17.4M15.4M14.4M13.1M21.7M11.8M12.0M6.08M5.80M4.69M
Shareholders' equity-16.8M-14.8M-13.8M-12.4M-20.9M-11.5M-11.7M-5.94M-5.41M-4.48M
Shares outstanding7.10B7.10B7.06B7.04B6.77B6.96B5.88B4.05B2.03B295.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-1.16M-424.0K-550.0K-762.4K-1.74M-878.1K-743.7K-999.9K-1.14M-1.36M
Capital spending-26.1K-58.0K-39.0K-5.91K-9.11K-3.38K
Free cash flow-1.19M-820.4K-1.78M-884.0K-1.15M-1.36M
Cash from investing-51.1K41.3K117.4K27.3K-293.5K-5.91K-9.11K-3.38K
Cash from financing1.19M419.1K432.7K644.2K2.13M884.0K743.7K999.9K1.12M1.38M
Change in cash-24.3K36.4K-90.9K90.9K

Open Financials

Filings

FilingDateTypeFiled with
NT 10-Q · Late filing noticeNov 16, 2026Explanation requestSEC
8-K · Current reportSep 2, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeSep 1, 2026Big-stake noticeSEC
3 · Initial statement of ownershipSep 1, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
10-Q · Quarterly reportAug 19, 2026Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2026Explanation requestSEC
10-Q · Quarterly reportMay 29, 2026Quarterly reportSEC
10-K · Annual reportMay 20, 2026Annual reportSEC
10-Q · Quarterly reportApr 6, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportMar 25, 2026Quarterly reportSEC
10-Q · Quarterly reportMar 11, 2026Quarterly reportSEC
10-K · Annual reportFeb 17, 2026Annual reportSEC
10-Q · Quarterly reportJan 2, 2026Quarterly reportSEC
10-Q · Quarterly reportDec 23, 2025Quarterly reportSEC
10-Q · Quarterly reportDec 17, 2025Quarterly reportSEC
10-K · Annual reportNov 24, 2025Annual reportSEC
10-Q · Quarterly reportOct 28, 2025Quarterly reportSEC
10-Q · Quarterly reportOct 23, 2025Quarterly reportSEC
10-Q · Quarterly reportOct 16, 2025Quarterly reportSEC
10-K · Annual reportSep 3, 2025Annual reportSEC
8-K · Current reportSep 3, 2025Current reportSEC
8-K · Current reportMar 22, 2024Management or board changeSEC
10-Q · Quarterly reportNov 21, 2022Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2022Explanation requestSEC
10-Q · Quarterly reportAug 22, 2022Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2022Explanation requestSEC
8-K · Current reportAug 4, 2022Current reportSEC
10-Q · Quarterly reportMay 20, 2022Quarterly reportSEC
NT 10-Q · Late filing noticeMay 16, 2022Explanation requestSEC
10-K · Annual reportApr 15, 2022Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2022Explanation requestSEC
DEF 14CMar 23, 2022Meeting noticeSEC
5 · Annual statement of ownershipJan 14, 2022Insider tradeSEC
SC 13D/A · Big-stake notice, amendedJan 14, 2022Big-stake noticeSEC
PRE 14CJan 14, 2022Meeting noticeSEC
10-Q · Quarterly reportNov 10, 2021Quarterly reportSEC
10-Q · Quarterly reportSep 24, 2021Quarterly reportSEC
10-Q · Quarterly reportSep 17, 2021Quarterly reportSEC
10-K · Annual reportSep 8, 2021Annual reportSEC
10-Q · Quarterly reportAug 12, 2021Quarterly reportSEC
10-Q · Quarterly reportAug 5, 2021Quarterly reportSEC
10-Q · Quarterly reportJul 23, 2021Quarterly reportSEC
10-K · Annual reportJul 1, 2021Annual reportSEC
10-Q · Quarterly reportMay 14, 2021Quarterly reportSEC
10-Q · Quarterly reportMay 7, 2021Quarterly reportSEC
10-Q · Quarterly reportApr 5, 2021Quarterly reportSEC
10-K · Annual reportFeb 5, 2021Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2019Explanation requestSEC
10-Q · Quarterly reportNov 19, 2018Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2018Explanation requestSEC
8-K · Current reportOct 9, 2018Current reportSEC
8-K · Current reportSep 28, 2018Current reportSEC
10-Q · Quarterly reportAug 17, 2018Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2018Explanation requestSEC
SC 13D · Big-stake noticeJun 29, 2018Big-stake noticeSEC
4 · Change in ownershipJun 26, 2018Insider tradeSEC
SC 13D · Big-stake noticeJun 6, 2018Big-stake noticeSEC
10-Q · Quarterly reportMay 21, 2018Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2018Explanation requestSEC
10-K · Annual reportApr 17, 2018Annual reportSEC
NT 10-K · Late filing noticeApr 2, 2018Explanation requestSEC
DEF 14CMar 20, 2018Meeting noticeSEC
PRE 14CMar 8, 2018Meeting noticeSEC
8-K · Current reportMar 7, 2018Management or board changeSEC
SC 13G/A · Big-stake notice, amendedFeb 5, 2018Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 1, 2018Big-stake noticeSEC
10-Q · Quarterly reportNov 20, 2017Quarterly reportSEC
NT 10-Q · Late filing noticeNov 14, 2017Explanation requestSEC
8-K · Current reportNov 3, 2017FinancingSEC
10-Q · Quarterly reportAug 14, 2017Quarterly reportSEC
10-Q · Quarterly reportMay 17, 2017Quarterly reportSEC
3 · Initial statement of ownershipMay 17, 2017Insider tradeSEC
NT 10-Q · Late filing noticeMay 15, 2017Explanation requestSEC
8-K · Current reportMay 4, 2017Current reportSEC
10-K · Annual reportApr 17, 2017Annual reportSEC
NT 10-K · Late filing noticeMar 31, 2017Explanation requestSEC
10-Q · Quarterly reportNov 22, 2016Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2016Explanation requestSEC
10-Q · Quarterly reportAug 22, 2016Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2016Explanation requestSEC
8-K · Current reportJul 26, 2016Management or board changeSEC
10-Q/A · Quarterly report, amendedJun 21, 2016Quarterly reportSEC
10-Q · Quarterly reportMay 27, 2016Quarterly reportSEC
NT 10-Q · Late filing noticeMay 17, 2016Explanation requestSEC
10-K · Annual reportApr 14, 2016Annual reportSEC
NT 10-K · Late filing noticeMar 30, 2016Explanation requestSEC
10-Q · Quarterly reportNov 23, 2015Quarterly reportSEC
NT 10-Q · Late filing noticeNov 17, 2015Explanation requestSEC
10-Q · Quarterly reportAug 18, 2015Quarterly reportSEC
NT 10-Q · Late filing noticeAug 17, 2015Explanation requestSEC
10-Q · Quarterly reportMay 19, 2015Quarterly reportSEC
NT 10-Q · Late filing noticeMay 18, 2015Explanation requestSEC
8-K · Current reportApr 29, 2015Current reportSEC
8-K · Current reportApr 21, 2015Meeting outcomeSEC
10-K · Annual reportApr 13, 2015Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2015Explanation requestSEC
DEF 14A · Proxy statementMar 17, 2015Meeting noticeSEC
PRE 14A · Preliminary proxy statementMar 3, 2015Meeting noticeSEC
10-Q · Quarterly reportNov 14, 2014Quarterly reportSEC
10-Q/A · Quarterly report, amendedAug 18, 2014Quarterly reportSEC
10-Q · Quarterly reportAug 14, 2014Quarterly reportSEC
10-Q · Quarterly reportMay 20, 2014Quarterly reportSEC
NT 10-Q · Late filing noticeMay 16, 2014Explanation requestSEC
10-K · Annual reportMar 31, 2014Annual reportSEC
4 · Change in ownershipMar 28, 2014Insider tradeSEC
4 · Change in ownershipMar 25, 2014Insider tradeSEC
4 · Change in ownershipMar 21, 2014Insider tradeSEC
4 · Change in ownershipMar 21, 2014Insider tradeSEC
10-Q · Quarterly reportNov 19, 2013Quarterly reportSEC
NTN 10QNov 18, 2013Other filingsSEC
8-K · Current reportSep 25, 2013Current reportSEC
10-Q · Quarterly reportAug 19, 2013Quarterly reportSEC
NT 10-Q · Late filing noticeAug 15, 2013Explanation requestSEC
10-Q · Quarterly reportMay 20, 2013Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2013Explanation requestSEC
10-K · Annual reportApr 16, 2013Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2013Explanation requestSEC
4 · Change in ownershipMar 28, 2013Insider tradeSEC
8-K · Current reportDec 14, 2012Current reportSEC
10-Q/A · Quarterly report, amendedDec 12, 2012Quarterly reportSEC
10-Q/A · Quarterly report, amendedDec 7, 2012Quarterly reportSEC
10-Q · Quarterly reportDec 5, 2012Quarterly reportSEC
10-Q · Quarterly reportDec 3, 2012Quarterly reportSEC
10-Q/A · Quarterly report, amendedNov 28, 2012Quarterly reportSEC
10-Q · Quarterly reportNov 21, 2012Quarterly reportSEC
10-K/A · Annual report, amendedNov 15, 2012Annual reportSEC
10-K · Annual reportNov 9, 2012Annual reportSEC
8-K · Current reportSep 12, 2012Management or board changeSEC
4 · Change in ownershipSep 11, 2012Insider tradeSEC
4 · Change in ownershipSep 7, 2012Insider tradeSEC
4 · Change in ownershipApr 26, 2012Insider tradeSEC
4 · Change in ownershipApr 19, 2012Insider tradeSEC
4 · Change in ownershipApr 17, 2012Insider tradeSEC
NT 10-K · Late filing noticeApr 2, 2012Explanation requestSEC
8-K · Current reportMar 19, 2012Material contractSEC
8-K · Current reportMar 8, 2012Management or board changeSEC
10-Q · Quarterly reportNov 15, 2011Quarterly reportSEC
NT 10-Q · Late filing noticeNov 15, 2011Explanation requestSEC
10-Q · Quarterly reportAug 15, 2011Quarterly reportSEC
10-Q · Quarterly reportMay 16, 2011Quarterly reportSEC
10-K · Annual reportApr 1, 2011Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2011Explanation requestSEC
4 · Change in ownershipMar 30, 2011Insider tradeSEC
EFFECT · Notice that a registration is effectiveJan 10, 2011Other filingsSEC
S-1/A · Registration statement, amendedJan 6, 2011Offer documentSEC
10-Q/A · Quarterly report, amendedJan 5, 2011Quarterly reportSEC
10-Q/A · Quarterly report, amendedJan 5, 2011Quarterly reportSEC
10-Q/A · Quarterly report, amendedJan 5, 2011Quarterly reportSEC
5 · Annual statement of ownershipDec 21, 2010Insider tradeSEC
8-K · Current reportDec 21, 2010Management or board changeSEC
S-1 · Registration statementDec 14, 2010Offer documentSEC
10-Q · Quarterly reportNov 15, 2010Quarterly reportSEC
8-K · Current reportNov 12, 2010Material contractSEC
8-K · Current reportAug 18, 2010Management or board changeSEC
10-Q · Quarterly reportAug 16, 2010Quarterly reportSEC
8-K · Current reportAug 6, 2010ResultsSEC
UPLOAD · Letter from the SECJun 24, 2010Other filingsSEC
10-Q · Quarterly reportMay 21, 2010Quarterly reportSEC
NT 10-Q · Late filing noticeMay 18, 2010Explanation requestSEC
10-K · Annual reportApr 15, 2010Annual reportSEC
4 · Change in ownershipApr 9, 2010Insider tradeSEC
4 · Change in ownershipApr 9, 2010Insider tradeSEC
CORRESP · Letter to the SECApr 8, 2010Other filingsSEC
10-K/A · Annual report, amendedApr 8, 2010Annual reportSEC
3/A · Initial statement of ownership, amendedApr 5, 2010Insider tradeSEC
3 · Initial statement of ownershipApr 5, 2010Insider tradeSEC
NT 10-K · Late filing noticeApr 1, 2010Explanation requestSEC
UPLOAD · Letter from the SECMar 22, 2010Other filingsSEC
4 · Change in ownershipFeb 17, 2010Insider tradeSEC
4 · Change in ownershipFeb 17, 2010Insider tradeSEC
3 · Initial statement of ownershipFeb 11, 2010Insider tradeSEC
4 · Change in ownershipFeb 5, 2010Insider tradeSEC
4 · Change in ownershipFeb 5, 2010Insider tradeSEC
8-K · Current reportFeb 2, 2010ResultsSEC
CORRESP · Letter to the SECJan 25, 2010Other filingsSEC
10-Q/A · Quarterly report, amendedJan 25, 2010Quarterly reportSEC
10-K/A · Annual report, amendedJan 25, 2010Annual reportSEC
3 · Initial statement of ownershipJan 21, 2010Insider tradeSEC
CORRESP · Letter to the SECJan 13, 2010Other filingsSEC
4 · Change in ownershipJan 13, 2010Insider tradeSEC
3 · Initial statement of ownershipJan 13, 2010Insider tradeSEC
8-K/A · Current report, amendedDec 31, 2009Current reportSEC
8-K · Current reportDec 24, 2009Current reportSEC
CORRESP · Letter to the SECDec 16, 2009Other filingsSEC
UPLOAD · Letter from the SECDec 15, 2009Other filingsSEC
10-Q · Quarterly reportNov 18, 2009Quarterly reportSEC
8-K/A · Current report, amendedNov 18, 2009Current reportSEC
NT 10-Q · Late filing noticeNov 16, 2009Explanation requestSEC
4 · Change in ownershipNov 12, 2009Insider tradeSEC
4 · Change in ownershipNov 10, 2009Insider tradeSEC
3 · Initial statement of ownershipNov 5, 2009Insider tradeSEC
8-K · Current reportOct 6, 2009FinancingSEC
10-Q · Quarterly reportAug 19, 2009Quarterly reportSEC
NT 10-Q · Late filing noticeAug 17, 2009Explanation requestSEC
8-K · Current reportJul 29, 2009Management or board changeSEC
10-Q · Quarterly reportMay 20, 2009Quarterly reportSEC
NT 10-Q · Late filing noticeMay 15, 2009Explanation requestSEC
10-K · Annual reportApr 15, 2009Annual reportSEC
NT 10-K · Late filing noticeApr 1, 2009Explanation requestSEC

This page holds 200 of 350 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Nutra Pharma Corp.’s releases · as of Aug 19, 2026

Common shares
7,159,727,214
Fully diluted
7,159,727,214

Fully diluted

LineSharesAs of
Common shares7,159,727,214Aug 19, 2026

Share count over time

CountShares
Aug 19, 20267,159,727,214

Open Cap table

Shareholders

StakeStakeSharesDateFiling
Pure Raw Supplies, LLC100.00%12MAug 21, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Rik J Deitsch
Other companies: Greenhouse Solutions Inc (CEO, Director · Jan 21, 2015 – Jan 21, 2015 · Past)
Operations Manager · Since at least Mar 21, 2014
Dale Vander PuttenChief Scientific Officer · Since at least Nov 5, 2026
Garry R PottruckDirector · Since at least Nov 5, 2026
Michael FlaxChairman, Chief Executive Officer, Chief Financial Officer · Since at least Nov 5, 2026
Stewart LonkyDirector - Audit & Compensation Committees · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Nutra Pharma Corp.